Company intelligence / Profile preview

Lisata Therapeutics

Basking Ridge, NJ, United Stateslisata.com ↗

Ownership: Public · LSTA
Development stage: Other

Overview

Lead candidate certepetide has demonstrated favorable safety, tolerability, and activity in clinical trials as an enhancer of standard-of-care chemotherapy for pancreatic cancer. Multiple ongoing Phase I/II trials are evaluating its ability to improve drug delivery and outcomes in various advanced solid tumor indications. Key data readouts are expected throughout late 2025.[7][8]

Therapeutic areas: Oncology
Modalities: Cyclic peptides (notably certepetide)Drug delivery enhancers for anti-cancer drugs (enabling small molecules, immunotherapies, RNA-based therapeutics)[6][10]
Industry: Biotech

Drug pipeline

13 assets

certepetide

12 more assets in the full pipeline.

Partnerships

GATC Health (AI-driven drug development collaboration) [3]Qilu Pharmaceutical Co. Ltd. (China trial partner)various academic collaborations [2]

Financials

Market cap: $8.9M
Total revenue: $170K
Enterprise value: $-1.5M

Beyond the preview

Go deeper on Lisata Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lisata Therapeutics.